-- Jarden在周四的一份报告中指出,Tabcorp Holdings (ASX:TAH) 可能面临新的监管执法调查带来的补救成本,且可能被认定为惯犯,但这两项因素都不足以解释该公司股价如此大幅下跌的原因。 澳大利亚交易报告和分析中心 (AUSTRAC) 正在调查该公司在反洗钱和反恐融资方面的合规情况,并对其识别和降低风险的能力表示担忧。 Jarden指出,由于监管机构的披露表明所有结果都在考虑范围内,因此无法确定是否会受到罚款。而以往的案例表明,如果监管机构对合作情况感到满意,则有可能免除罚款。 这家股票研究公司表示,AUSTRAC此前对博彩行业的罚款金额从零到4.5亿澳元不等,并补充说,他们认为此次事件对Tabcorp的营收影响有限。 调查披露后,该公司股价大幅下跌。Jarden表示,以目前的股价来看,“该股似乎反映的成本影响远超既有先例所支持的范围”。 Jarden维持对Tabcorp的“增持”评级,目标价为1.05澳元。Jarden表示,如果澳大利亚交易报告和分析中心(Austrac)提起民事处罚诉讼或Tabcorp计提与此案相关的准备金,Jarden将重新评估该评级。 该公司股价在上周五的交易中下跌了13%。
Related Articles
Apollo Micro Systems Clinches Orders Worth INR510 Million; Shares Up 4%
Defense manufacturer Apollo Micro Systems (NSE:APOLLO, BOM:540879) has secured new orders worth a total of 510.3 million Indian rupees, according to a Friday filing to the Indian stock exchanges.Of the total, orders of 174.8 million rupees from the Ministry of Defence, Government of India, contracts of 95.3 million rupees from public sector defense undertakings, and orders worth 240.2 million rupees from private companies.The company's shares were up nearly 4% in recent trade.
PKU HealthCare Gets Nod for Tofacitinib Citrate's Marketing
PKU HealthCare (SHE:000788) obtained approval from China's National Medical Products Administration for the marketing of Tofacitinib Citrate, according to a Shenzhen bourse filing on Friday.The drug is a potent Janus kinase (JAK) inhibitor, primarily used for patients suffering from chronic autoimmune conditions, including ankylosing spondylitis, rheumatoid arthritis and psoriatic arthritis.The healthcare company's share rose 1% during the afternoon trade.
Toyota Expects Lower Fiscal 2027 Profit Amid Tariff, Cost Pressures
Toyota Motor (TYO:7203) forecasts weaker profit for fiscal 2027 as rising material and energy costs linked to Middle East tensions are expected to weigh on earnings, according to a Friday filing on the Tokyo Stock Exchange.The automaker expects net income attributable to shareholders to decline 22% to 3 trillion yen in the year ending March 2027, with basic earnings per share projected at 251.25 yen. Revenue is expected to rise slightly to 51 trillion yen.For the fiscal year ended March 2026, Toyota reported net profit attributable to shareholders of 3.848 trillion yen, down 19% from a year earlier, while revenue rose 5.5% to 50.7 trillion yen. Earnings per share fell to 295.25 yen from 359.56 yen a year earlier.The company raised its annual dividend to 95 yen per share from 90 yen and forecast a payout of 100 yen for fiscal 2027.